OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Director received an award of 13K CORT derivative securities | OQRO

Home
Insider trades
Corcept Therapeutics
Director received an award of 13K CORT derivative securities

Insider trades

Insider trade

Director received an award of 13K CORT derivative securities

Traded May 21, 2026 · Filed May 27, 2026

CORCorcept TherapeuticsCORT

13K
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 21, 2026
Reporting period: Not applicable
Filed with the SEC: May 27, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001193125-26-239683
Filed / recorded

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

May 27, 2026, 1:28 AM UTC

Added to OQRO

Oct 6, 2026, 7:14 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

CORCEPT THERAPEUTICS INC

Issuer CIK

1088856

Ticker

CORT

Reporting person

Kimberly Park

Relationship

Director

Security

Stock Option (right to buy)

Table

Derivative (Table II)

Transaction date

May 21, 2026

Transaction code

Shares / units

12,500

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

12,500

Ownership form

Direct

Amendment

Footnotes from the filing

Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.

Around the same time

James N Wilson (Director) sold ~$345K of Corcept Therapeutics

Planned saleFiled 4mo ago

James N Wilson (Director) sold ~$487K of Corcept Therapeutics

Planned saleFiled 4mo ago

David L MahoneyDirector

Filed 4mo ago

Sold

~$1.69M20K sh @ $84.53

Traded Jun 17 · filed 2 days laterNot under a reported trading plan

A Corcept Therapeutics director sold $1.69M of Corcept Therapeutics shares. The filing does not indicate a pre-arranged trading plan.

More Official record